Biosimilar vs RPh NOW Pharmacy Usage & Stats

Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics. ** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
  • Apple App Store
  • Paid
  • Medical

Store Rank

- -

RPh Now uses peer-to-peer technology to connect pharmacists and pharmacy technicians with businesses that request them on an as needed basis. Just like other peer-to-peer apps the pharmacy requests the services of other users that will cover their staffing needs. Just create your account, choose the areas you are willing to work at and wait for the notifications to come in. It doesn’t matter if you are fully employed and want to make some extra money on your day off or just looking to work a few hours a week, RPh Now is free for pharmacists and pharmacy technicians with no hidden charges or fees. You just have to accept a shift and show up!
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

Biosimilar vs. RPh NOW Pharmacy ranking comparison

Compare Biosimilar ranking trend in the past 28 days vs. RPh NOW Pharmacy

BiosimilarBiosimilar#132

Rank

Biosimilar vs. RPh NOW Pharmacy ranking by country comparison

Compare Biosimilar ranking trend in the past 28 days vs. RPh NOW Pharmacy

All categories

No Data Available

Medical

App
Top Country
Rank
#132
- -
- -

Compare to any site with our free trial

Get started
Biosimilar VS.
RPh NOW Pharmacy

December 19, 2024